Vaccines
Latest News
Serious problems rare in ages 5-11 from COVID vaccine
“This study demonstrates that unvaccinated children hospitalized for COVID-19 could experience severe disease and reinforces the importance of...
News
FDA backs Pfizer booster for 12- to 15-year-olds
The agency also shortened the recommended time between a second dose and the booster to 5 months or more,
Article
Why mRNA COVID vaccines are preferred (and why patients should be reassured)
On December 16, 2021, the Advisory Committee on Immunization Practices (ACIP) voted to preferentially recommend messenger RNA (mRNA) vaccines over...
Latest News
Pfizer COVID vaccine for younger children hits snag
Pfizer reported that its 3-microgram dose generated a protective immune response in those aged 6-24 months but didn’t generate adequate immunity...
News
COVID-19 interrupted global poliovirus surveillance and immunization
The pandemic has had a significant impact on polio, accounting for much of this year’s increase in cases.
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
Opinion
Booster recommendations for pregnant women, teens, and other groups explained
CDC makes specific statements about individuals who are pregnant.
News
FDA authorizes Pfizer boosters for 16- and 17-year-olds
Early studies suggest that booster doses may be necessary to keep Omicron at bay, at least until new variant-specific vaccines are ready next...
ID Consult
Mumps: Sometimes forgotten but not gone
In the mid-2000s, mumps cases started to rise again, with more than 28,000 reported between 2007 and 2019.
Latest News
Vaccine protection drops against Omicron, making boosters crucial
“The strains so far vary by their degree of being neutralized by the antibodies from these vaccines, but they are being neutralized nonetheless...
From the Journals
Intent to vaccinate kids against COVID higher among vaccinated parents
“Parental vaccine hesitancy is a major issue for schools resuming in-person instruction,” according to the authors of a new paper.